Abstract
Herpes disease is caused by Herpes simplex virus (HSV). It has become one of the global health problems. This paper reports a method for HSV type testing. First specific primers sequence for HSV-1 and HSV-2 were selected, designed, and synthesized. Then, these amplification products were proved by sequencing and analysis. Lastly, we optimized the reaction system and PCR reaction program by orthogonal design and sensitivity testing. Results showed that the lowest concentration in HSV-type testing is about 6.67 × 106 copies/ml. Moreover, the specificity of detection was very high. So, this method has very great potentials for HSV type testing in clinical practice.
Introduction
Herpes disease, caused by Herpes Simplex Virus (HSV), has become one of the global health problems (Looker et al., 2017). HSV can cause high infant morbidity and infant mortality with mother-to-child transmission (James and Kimberlin, 2015). It includes Herpes simplex virus type 1 (HSV-1) and Herpes simplex virus type 2 (HSV-2), which are double-stranded DNA viruses belonging to the Herpesviridae family (Salvatore et al., 2019), causing persistent infection in the trigeminal or lumbosacral ganglia (Christine et al., 2016). Besides, the HSV-associated disease becomes malignant when the virus gets access to the central nervous system, which may result in herpes encephalitis (Koujah et al., 2018). HSV-1 mainly causes infection of skin other than genital organs, mucosa (oral mucosa), and organs (brain). HSV-2 mainly causes genital musoca skin infection. However, in these years, it is found that HSV-1 can be transmitted via sexual contact and genital herpes may also occur due to transmission of HSV-1 by oral-genital contact (Christian et al., 2019; Khan et al., 2019), which means that the line between HSV-1 and HSV-2 infection has become increasingly blurred and both viruses can infect genital epithelial cells and produce the same pathological mechanisms. And given that the latest literature reports that the HSV-2 has infected more than 700 million people worldwide, early selection of appropriate methods for accurate diagnosis of HSV is particularly important (Dropulic et al., 2019; Harfouche et al., 2021; Rice, 2021).
At present, HSV detection methods mainly include cytology, immunology, molecular biology detection and so on. For example; 1) Virus isolation and culture is a reliable basis for definitive diagnosis of HSV infection in clinical practice today, but its operation is cumbersome and the time is long, and also needs other methods to assist identification (Qi et al., 2020; Wijesinghe et al., 2021). 2) Immunoassay has high specificity and insufficient sensitivity, which may lead to false negative (Chauhan et al., 2018; Fatima et al., 2021). 3) Nucleic acid detection methods in molecular biology have outstanding advantages, such as high sensitivity and specificity (Chen et al., 2020; Tang et al., 2020; Chen et al., 2022; Liu et al., 2022). So, this study aimed to design a PCR typing detection method for detecting HSV-1 or HSV-2 in the same reaction system (Figure 1), and it has high specificity and is difficult to appear with false positive. This work hopes to provide some new ideas for researchers in HSV-type identification in clinical practice.
FIGURE 1
The flowchart for optimization of a high specificity typing PCR method. PCR, polymerase chain reaction.
Materials and methods
Materials
We chose the CDS region of HSV-1 and HSV-2 as the target gene sequence. Then we compared homologous sequences on NCBI to identify the target sequence. The plasmids from HSV-1 and plasmid from HSV-2 were synthesized by Sangon Biotech (Shanghai, China) (Table 1). The MIX used for PCR (including Taq DNA polymerase, dNTPs, buffer, etc.) was a 2x concentrated PCR amplification premixed solution purchased from Sangon Biotech (Shanghai, China). PCR not only removes the complex operation process by adding templates and primers to the system, but also saves time. According to the design principles for PCR primers, those primers were designed by using primer 5 software for our selected gene regions (Table 2).
TABLE 1
| Primer name | Sequence information (5′–3′) | Amplification length (bp) |
|---|---|---|
| Plasmid-HSV-1 | GTC​ATT​CAG​ATA​TCC​TGT​CTG​CTC​TAC​GAC​CTG​TCC​ACC​ACC​GCC​CTG​GAG​CAC​GTC​CTC​CTG​TTT​TCG​CTC​GGT​TCC​TGC​GAC​CTC​CCC​GAA​TCC​CAC​CTG​AAC​GAG​CTG​GCG​GCC​AGG​GGC​CTG​CCC​ACG​CCC​GTG​GTT​CTG​GAA​TTC​GAC​AGC​GAA​TTC​GAG​ATG​CTG​TTG​GCC​TTC​ATG​ACC​CTT​GTG​AAA​CAG​TAC​GGC​CCC​GAG​TTC​GTG​ACC​GGG​TAC​AAC​ATC​ATC​AAC​TTC​GAC​TGG​CCC​TTC​TTG​CTG​GCC​AAG​CTG​ACG​GAC​ATT​TAC​AAG​GTC​CCC​CTG​GAC​GGG​TAC​GGC​CGC​ATG​AAC​GGC​CGG​GGC​GTG​TTT​CGC​GTG​TGG​GAC​ATA​GGC​CAG​AGC​CAC​TTC​CAG​AAG​CGC​AGC​AAG​ATA​AAG​GTG​AAC​GGC​ATG​GTG​AAC​ATC​GAC​ATG​TAC​GGG​ATT​ATA​ACC​GAC​AAG​ATC​AAG​CTC​TCG​AGC​TAC​AAG​CTC​AAC​GCC​GTG​GCC​GAA​GCC​GTC​CTG​AAG​GAC​AAG​AAG​AAG​G | 490 |
| Plasmid-HSV-2 | CAG​CCC​TCG​CCC​CTG​GGT​CGG​GAG​GCG​GTG​GAA​CAG​TTC​TTC​CGG​CAC​GTG​CGC​GCC​CAG​CTG​AAC​ATC​CGC​GAG​TAC​GTA​AAG​CAA​AAC​GTC​ACC​CCC​AGG​GAA​ACC​GCC​CTG​GCG​GGA​GAC​GCG​GCC​GCC​GCC​TAC​CTG​CGC​GCG​CGC​ACG​TAT​GCC​CCG​GCG​GCC​CTC​ACG​CCC​GCC​CCC​GCG​TAC​TGC​GGG​GTC​GCA​GAC​TCG​TCC​ACC​AAA​ATG​ATG​GGA​CGT​CTG​GCG​GAA​GCA​GAA​AGG​CTC​CTA​GTC​CCC​CAC​GGC​TGG​CCC​GCG​TTC​GCA​CCA​ACA​ACC​CCC​GGG​GAC​GAC​GCG​GGG​GGC​GGC​ACT​GCC​GCC​CCC​CAG​ACC​TGC​GGA​ATC​GTC​AAG​CGC​CTC​CTC​AAG​CTG​GCC​GCC​ACG​GAG​CAG​CAG​GGC​ACG​ACG​CCC​CCG​GCG​ATC​GCG​GCT​CTC​ATG​CAG​GAC​GCG​TCG​GTC​CAA​ACC​CCC​CTG​CCC​GTG​TAC​AGG​ATT​ACC​ATG​TCC​CCG​ACC​GGC​CAG​GCG​TTT​GCC​GCG​GCG​G | 490 |
Sequence information for plasmid used for polymerase chain reaction.
TABLE 2
| Primer name | Sequence information (5′–3′) | Amplification length (bp) |
|---|---|---|
| PCR-H1-F | ATA​TCC​TGT​CTG​CTC​TAC​GAC​CTG​TCC​ACC​AC | 469 |
| PCR-H1-R | TCC​TTC​AGG​ACG​GCT​TCG​GCC​ACG​GCG​TTG​AG | |
| PCR-H2-F | AAA​TGA​TGG​GAC​GTC​TGG​CGG​AAG​CAG​AAA​GG | 267 |
| PCR-H2-R | GCA​AAC​GCC​TGG​CCG​GTC​GGG​GAC​ATG​GTA​A |
Sequence information of the primers used for polymerase chain reaction.
Design primer for PCR assays
We design the two pairs of designed primers for PCR and verify them useful. The reaction components for PCR assays were as follows: 12.5 μl PCR Mix, 10 μl dd H2O, 0.5 μl HSV-1 template or HSV-2 template, 1 μl primer 1-F and 1 μl primer 1-R or 1 μl primer 2-F and 1 μl primer 2-R. It was amplified in Eppendorf Master cycler PCR instrument (Eppendorf, Hamburg, Germany) for predegeneration at 72°C for 5 min, and then 35 cycles at 95°C 30 s, 58°C for 30 s, and 72°C 30 s, followed by a final extension at 72°C for 10 min. The PCR products were sequenced by Sangon Biotech (Shanghai, China), after being analyzed by 1% agarose gel.
PCR typing assays
To verify whether the typing PCR was feasible. The reaction components for the PCR assays were as follows:12.5 μl PCR Mix, 10 μl dd H2O, 0.5 μl HSV-1 template or HSV-2 template, 0.5 μl primer 1-F, 0.5 μl primer 1-R, 0.5 μl primer 2-F, 0.5 μl primer 2-R. It was amplified in Eppendorf Master cycler PCR instrument (Eppendorf, Hamburg, Germany) for predegeneration at 95°C for 5 min, and then 35 cycles at 95°C 30 s, 58°C for 30 s, and 72°C 30 s, followed by a final extension at 72°C for 10 min. Finally, the PCR products were analyzed by 1% agarose gel.
Optimization of reaction system by orthogonal design
Referring to others’ work (Zeng et al., 2015; Zeng et al., 2016; Tang et al., 2018; Mou et al., 2019; Gong et al., 2021), the gradient experiments for single factor and multilevel orthogonal design were integrated and results from the two experiments were analyzed to find the best PCR reaction system (Table 3).
TABLE 3
| Number | dd H2O | PCR MIX | Primer 1 | Primer 2 | DNA |
|---|---|---|---|---|---|
| 1 | 7.0 | 15.0 | 1.5 | 1.0 | 0.5 |
| 2 | 10.0 | 12.5 | 1.2 | 0.8 | 0.5 |
| 3 | 13.0 | 10.0 | 0.9 | 0.6 | 0.5 |
| 4 | 7.0 | 15.0 | 1.25 | 1.25 | 0.5 |
| 5 | 10.0 | 12.5 | 1.0 | 1.0 | 0.5 |
| 6 | 13.0 | 10.0 | 0.75 | 0.75 | 0.5 |
| 7 | 7.0 | 15.0 | 1.0 | 1.5 | 0.5 |
| 8 | 10.0 | 12.5 | 0.8 | 1.2 | 0.5 |
| 9 | 13.0 | 10.0 | 0.6 | 0.9 | 0.5 |
Reaction system information for optimization by orthogonal design (μl).
Optimization of PCR reaction program by orthogonal design
As shown in Table 4, the gradient experiments for single factor and multilevel orthogonal design were integrated and results from the two experiments were analyzed to find the best PCR reaction conditions. The predegeneration was at 95°C for 5 min and final extension was at 72°C for 10 min.
TABLE 4
| Nos | Degeneration temperature (°C) | Degeneration time (s) | Annealing temperature (°C) | Annealing time (s) | Extension temperature (°C) | Extension time (s) |
|---|---|---|---|---|---|---|
| 1 | 95 | 20 | 57 | 25 | 72 | 25 |
| 2 | 95 | 20 | 58 | 30 | 72 | 35 |
| 3 | 95 | 20 | 59 | 35 | 72 | 45 |
| 4 | 95 | 20 | 60 | 40 | 72 | 55 |
| 5 | 95 | 25 | 57 | 25 | 72 | 25 |
| 6 | 95 | 25 | 58 | 30 | 72 | 35 |
| 7 | 95 | 25 | 59 | 35 | 72 | 45 |
| 8 | 95 | 25 | 60 | 40 | 72 | 55 |
| 9 | 95 | 30 | 57 | 25 | 72 | 25 |
| 10 | 95 | 30 | 58 | 30 | 72 | 35 |
| 11 | 95 | 30 | 59 | 35 | 72 | 45 |
| 12 | 95 | 30 | 60 | 40 | 72 | 55 |
| 13 | 95 | 35 | 57 | 25 | 72 | 25 |
| 14 | 95 | 35 | 58 | 30 | 72 | 35 |
| 15 | 95 | 35 | 59 | 35 | 72 | 45 |
| 16 | 95 | 35 | 60 | 40 | 72 | 55 |
Information for polymerase chain reaction program optimization by orthogonal design.
Sensitivity experimental design
We diluted the plasmid of HSV-1 and plasmid from HSV-2 at 6.67 × 1010 copies/ml to 6.67 × 106 copies/ml concentrations in a 10-fold gradient with dd H20. Plasmids (from 6.67 × 108 copies/ml to 6.67 × 105 copies/ml) with different concentrations were added into the reaction system. It was then amplified in a PCR instrument (Eppendorf, Hamburg, Germany) for predegeneration at 95°C for 5 min, and then 35 cycles at 95°C 20 s, 59°C for 35 s, and 72°C 45 s, followed by a final extension at 72°C for 10 min.
Results and discussion
The feasibility of primers
The results from verifications of our designed primers are shown in Figure 2 below. The location of the bands was correct, and the bands had high specificity. Then the products were sent to company (Shanghai, China) for sequencing. The sequencing results are shown in Figure 3, and the results are correct. The designed primers were then used for subsequent experiments.
FIGURE 2
Agarose gel electrophoresis of amplification product. M: Marker; Lane 1, primers PCR-H1-F and primer PCR-H1-R; Lane 2, primers PCR-H2-F and primer PCR-H2-R; Lane 3, Negative control of primers PCR-H1-F and primer PCR-H1-R; Lane 4, Negative control of primers PCR-H2-F and primer PCR-H2-R.
FIGURE 3
The sequencing result for herpes simplex virus polymerase chain reaction products. (A) The sequencing peak map for HSV-1-F; (B) The sequencing peak map for HSV-1-R; (C) Assembling from sequencing data of herpes simplex virus 1; (D) The sequencing peak map for HSV-2-F; (E) The sequencing peak map for HSV-2-R; (F) Assembling from sequencing data for herpes simplex virus 2.
PCR typing system detection
Using the confirmed reaction system, we added the HSV-1 template plasmids into tube-1, and template plasmids from HSV-2 into tube-2. We then added dd H2O into tube-3 as a negative control. The results are shown in Figure 4. The obtained bands’ specificity was high, and nonspecific amplification did not appear in our result.
FIGURE 4
Agarose gel electrophoresis of typing polymerase chain reaction product. M: marker; line 1, typing polymerase chain reaction product of herpes simplex virus 1; line 2, typing polymerase chain reaction product of herpes simplex virus 2; Lane 3, Negative control.
Optimization of reaction system
Nine different combinations of experiments were analyzed and optimized due to differences in the templates, primers, and MIX. As shown in Figure 5, we can see that 1, 2, 3, 4, 5, and 7 bands for HSV-1 were greater than 6, 8, and 9. 5, 7, 8, and 9 for the nine HSV-2 systems were significantly brighter than for other systems. Combining above analysis, system 5 (12.5 μl PCR Mix, 10 μl dd H2O, 0.5 μl HSV-1 template or HSV-2 template, 0.5 μl primer 1-F, 0.5 μl primer 1-R, 0.5 μl primer 2-F, 0.5 μl primer 2-R) was the best choice.
FIGURE 5
Agarose gel electrophoresis of polymerase chain reaction product of reaction system optimization (A) Agarose gel electrophoresis for polymerase chain reaction product of optimization of herpes simplex virus -1 reaction system. M: Marker; Lane 1–9, primers PCR-H1-F and PCR-H1-R PCR product of optimization of herpes simplex virus 1 reaction system. (B) Agarose gel electrophoresis for polymerase chain reaction product optimization of herpes simplex virus 2 reaction system. M: Marker; Lane 1–9, polymerase chain reaction product of optimization of herpes simplex virus 2 reaction system.
Optimization of the PCR reaction program
Different combinations of 16 sets of PCR reaction programs were analyzed and optimized, and the results are shown in Figure 6. In HSV-2’s program optimization, the third program band was brighter than in the other programs. With HSV-1’s program optimization, the difference in the results was small. Combining both analyses, the third program band was clear, and had good stability. So, program 3 (degeneration time 20 s, annealing temperature 59 degrees, annealing time 35 s, extension time 45 s) was the best reaction program.
FIGURE 6
Agarose gel electrophoresis for polymerase chain reaction product optimization of polymerase chain reaction program. (A,B) Product of herpes simplex virus 1; M: marker; line 1–16, PCR product optimization of polymerase chain reaction program for herpes simplex virus 1; (C,D) Product of herpes simplex virus 2; M: marker; line 1–16, polymerase chain reaction product optimization of polymerase chain reaction program for herpes simplex virus 2.
Sensitivity inspection
The primer length designed in this experiment was more than 30 bp, slightly larger than the traditional PCR primer design length (The traditional PCR primer design length is about 15–30 bp). It enhanced the specificity of PCR amplification, leading to a certain decrease in the amplification efficiency as shown by results in Figure 7. 6.67 × 108 copies/ml-6.67 × 106 copies/ml can get bands, 6.67 × 105 copies/ml can’t get bands, so the lowest concentration in HSV-type testing is about 6.67 × 106 copies/ml.
FIGURE 7
Agarose gel electrophoresis of polymerase chain reaction product sensitivity inspection. (A) Sensitivity inspection of herpes simplex virus 1. polymerase chain reaction product optimization of herpes simplex virus 1 reaction system; M: marker; line 1–4, Sensitivity inspection of herpes simplex virus 1 reaction system; line 5, negative control. (B) Sensitivity inspection of herpes simplex virus 2. M: marker; line 1–4, Sensitivity inspection of herpes simplex virus 1 reaction system; line 5, negative control.
Conclusion
The current study on HSV detection was based on the HSV typing PCR reaction system and optimization of reaction procedures. Since the line between HSV-1 and HSV-2 infection has become increasingly blurred, it was necessary to establish a PCR reaction system suitable for HSV typing detection. The system is influenced by multiple aspects, including interactions of DNA concentration, primers concentration, and 2 × Taq PCR Master Mix content. This experiment is slightly different from the establishment and optimization of traditional PCR reaction system (Yang et al., 2020). The traditional PCR reaction system is a single-factor investigation method to determine the content of various components in the system. Although the herein results are intuitive, it ignores the integrity of the system (the mutual influence and internal connection between each component). The experiment adopts the orthogonal optimization method, which makes up for the deficiency of single-factor investigation, takes into account the intrinsic correlation of components, shortens the time to optimize the experimental method and saves energy. The establishment and optimization of traditional PCR reaction system usually examines the influence of five factors on the system, including (DNA template, primer, Tap DNA primer, polymerase, Mg2+, dNTP), this experiment adopted 2 × Taq PCR Master Mix, to transform the original complex 5 factors into 3 factors, simplifying the establishment and optimization of the reaction system and facilitating subsequent experiments. This HSV typing detection system with high availability of HSV with high stability was verified by suitable target genes and designed primers.
Statements
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Materials, further inquiries can be directed to the corresponding authors.
Author contributions
ZC and ZYH proposed the research idea. BYT, ZRT, and KXZ participated in the PCR experiment subjects and wrote the first draft. ZYH and HC design the HSV-typing PCR Primers. XFL and LC participated the sequence and statistical analysis. PHML and FWNC prepared the Figures and Tables. ZC and YD provides research materials, reagents, patients, experimental samples, instruments, etc. All authors contributedto revising and editing the manuscript and approved the submitted version.
Funding
This work was supported by the grant from the National Natural Science Foundation of China (61901168), Hunan Provincial Natural Science Foundation of China (2022JJ30229), Educational project of Hunan Province of China (Nos 21B0526, 21B0736). Hunan Key Research and Development Program (No. 2021SK 2003).
Conflict of interest
Author LC was employed by Guangzhou Wondfo iCubate Biotech Co. Ltd. Author HW was employed by Wondfo Biotech Co., Ltd.
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
ChauhanV.Goyalk.SinghM. (2018). Identification of broadly reactive epitopes targeting major glycoproteins of Herpes simplex virus (HSV) 1 and 2 - an immunoinformatics analysis. Infect. Genet. Evol.61, 24–35. 10.1016/j.meegid.2018.03.004
2
ChenH.XiaoZ.ChuZ.JinL.LiS.DengY.et al (2020). Novel detection of norovirus and double Clostridium difficile in a closed cartridge system. J. Biomed. Nanotechnol.16, 954–964. 10.1166/jbn.2020.2933
3
ChenZ.ZhaoK. X.HeZ. Y.JinL.WuZ.YanJ.et al (2022). Development and evaluation of a thermostatic nucleic acid testing device based on magnesium pyrophosphate precipitation for detecting enterocytozoon hepatopenaei. Chin. Chem. Lett.33, 4053–4056. 10.1016/j.cclet.2022.01.072
4
ChristianM. Z.DavidM.KnipeP. E.PellettR. H. (2019). Classification of human Herpesviridae proteins using domain-architecture aware inference of orthologs (DAIO). Virology529, 29–42. 10.1016/j.virol.2019.01.005
5
ChristineJ.SamiL.GottliebA. W. (2016). Status of vaccine research and development of vaccines for herpes simplex virus. Vaccine34, 2948–2952. 10.1016/j.vaccine.2015.12.076
6
DropulicL.OestreichM.PietzH.LaingK.HunsbergerS.LumbardK.et al (2019). A randomized, double-blinded, placebo-controlled, phase 1 study of a replication-defective herpes simplex virus (HSV) type 2 vaccine, HSV529, in adults with or without HSV infection. J. Infect. Dis.220, 990–1000. 10.1093/infdis/jiz225
7
FatimaS.KumariA.DwivediV. (2021). Advances in adjunct therapy against tuberculosis: Deciphering the emerging role of phytochemicals. MedComm2, 494–513. 10.1002/mco2.82
8
GongY.NieL.DaiL. (2021). Beyond proteins: Ubiquitylation of lipopolysaccharide to fight bacteria. MedComm2, 855–857. 10.1002/mco2.86
9
HarfoucheM.Abu-HijlehF. M.JamesC.LookerK. J.Abu-RaddadL. J. (2021). Epidemiology of herpes simplex virus type 2 in sub-saharan africa: Systematic review, meta-analyses, and meta-regressions. Eclinicalmedicine35, 100876. 10.1016/j.eclinm.2021.100876
10
JamesS. H.KimberlinD. W. (2015). Neonatal herpes simplex virus infection. Infect. Dis. Clin. North Am.29, 391–400. 10.1016/j.idc.2015.05.001
11
KhanH.KhanA.LiuY.WangS.BibiS.XuH.et al (2019). CRISPR-Cas13a mediated nanosystem for attomolar detection of canine parvovirus type 2. Chin. Chem. Lett.30, 2201–2204. 10.1016/j.cclet.2019.10.032
12
KoujahL.SuryawanshiR. K.ShuklaD. (2018). Pathological processes activated by herpes simplex virus-1 (HSV-1) infection in the cornea. Cell. Mol. Life Sci.76, 405–419. 10.1007/s00018-018-2938-1
13
LiuS.HeX.ZhangT.ZhaoK.XiaoC.TongZ.et al (2022). Highly sensitive smartphone-based detection of Listeria monocytogenes using SYTO9. Chin. Chem. Lett.33, 1933–1935. 10.1016/j.cclet.2021.11.051
14
LookerK. J.MagaretA. S.MayM. T.TurnerK. M. E.VickermanP.NewmanL. M.et al (2017). First estimates of the global and regional incidence of neonatal herpes infection. Lancet Glob. Health5, 300–309. 10.16/S2214-109X(16)30362-X
15
MouX. B.ShengD. N.ChenZ.LiuM.LiuY.DengY.et al (2019). In-situ mutation detection by magnetic beads-probe based on single base extension and its application in genotyping of hepatitis B virus pre-C region 1896nt locus single nucleotide polymorphisms. J. Biomed. Nanotechnol.15, 2393–2400. 10.1166/jbn.2019.2862
16
QiJ.HeJ.LiuC.JinS.GaoR.YangX.et al (2020). Pulmonary Staphylococcus aureus infection regulates breast cancer cell metastasis via neutrophil extracellular traps (NETs) formation. MedComm1, 188188–201201. 10.1002/mco2.22
17
RiceS. A. (2021). Release of HSV-1 cell-free virions: Mechanisms, regulation, and likely role in human-human transmission. Viruses13, 2395. 10.3390/v13122395
18
SalvatoreC.LucaF.AlbertoB.CesareD.GiuliaA.FrancescaG.et al (2019). Herpes virus, oral clinical signs and QoL: Systematic review of recent data. Viruses11, 463. 10.3390/v11050463
19
TangC. L.HeZ. Y.LiuH. M.XuY.HuangH.YangG. J.et al (2020). Application of magnetic nanoparticles in nucleic acid detection. J. Nanobiotechnology18, 62. 10.1186/s12951-020-00613-6
20
TangY. J.AliZ. S.DaiJ. G.LiuX. L.WuY. Q.ChenZ.et al (2018). Single-nucleotide polymorphism genotyping of ExoS in Pseudomonas aeruginosa using dual-color fluorescence hybridization and magnetic separation. J. Biomed. Nanotechnol.14, 206–214. 10.1166/jbn.2018.2525
21
WijesingheV. N.FaroukI. A.ZabidiN. Z.PuniyamurtiA.ChooW. S.LalS. K. (2021). Current vaccine approaches and emerging strategies against herpes simplex virus (HSV). Expert Rev. Vaccines20, 1077–1096. 10.1080/14760584.2021.1960162
22
YangJ.ZhangN.LvJ.ZhuP.PanX.HuJ. Q. G.et al (2020). Comparing the performance of conventional PCR, RTQ-PCR, and droplet digital PCR assays in detection of Shigella. Mol. Cell. Probes51, 101531. 10.1016/j.mcp.2020.101531
23
ZengB.HuangX.HuangL. K.ZhangJ.YanH. D.LuoD.et al (2015). Optimization of SCoT-PCR reaction system in dactylis glomerata by orthogonal design. Genet. Mol. Res.14, 3052–3061. 10.4238/2015.April.10.15
24
ZengB.YanH. D.HuangL. K.WangY. C.WuJ. H.HuangX.et al (2016). Orthogonal design in the optimization of a start codon targeted (SCoT) PCR system in roegneria kamoji ohwi. Genet. Mol. Res.15, 15048968. 10.4238/gmr15048968
Summary
Keywords
HSV-1, HSV-2, orthogonal design, primer design, HSV typing
Citation
Chen Z, Zhao K, Tan B, Tong Z, He Z, Luo X, Cai L, Wang H, Leung PHM, Chow FW-N, Chen H and Deng Y (2022) Development of a high specificity typing method for the detection of herpes simplex virus. Front. Bioeng. Biotechnol. 10:955713. doi: 10.3389/fbioe.2022.955713
Received
29 May 2022
Accepted
18 July 2022
Published
17 August 2022
Volume
10 - 2022
Edited by
Hongna Liu, iRepertore Inc., United States
Reviewed by
Xinjiang Cao, Anyang Institute of Technology, China
Bin Liu, Nanjing Medical University, China
Qi You, Nanjing University, China
Updates
Copyright
© 2022 Chen, Zhao, Tan, Tong, He, Luo, Cai, Wang, Leung, Chow, Chen and Deng.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ziyu He, 18774657648@163.com; Yan Deng, hndengyan@126.com
This article was submitted to Biosensors and Biomolecular Electronics, a section of the journal Frontiers in Bioengineering and Biotechnology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.